Targeting calcium signaling in cancer therapy

The intracellular calcium ions (Ca2+) act as second messenger to regulate gene transcription, cell proliferation, migration and death. Accumulating evidences have demonstrated that intracellular Ca2+ homeostasis is altered in cancer cells and the alteration is involved in tumor initiation, angiogenesis, progression and metastasis. Targeting derailed Ca2+ signaling for cancer therapy has become an emerging research area. This review summarizes some important Ca2+ channels, transporters and Ca2+-ATPases, which have been reported to be altered in human cancer patients. It discusses the current research effort toward evaluation of the blockers, inhibitors or regulators for Ca2+ channels/transporters or Ca2+-ATPase pumps as anti-cancer drugs. This review is also aimed to stimulate interest in, and support for research into the understanding of cellular mechanisms underlying the regulation of Ca2+ signaling in different cancer cells, and to search for novel therapies to cure these malignancies by targeting Ca2+ channels or transporters.

[1]  V. Firlej,et al.  Role of cationic channel TRPV2 in promoting prostate cancer migration and progression to androgen resistance. , 2010, Cancer research.

[2]  Liwu Fu,et al.  Elevated Orai1 expression mediates tumor-promoting intracellular Ca2+ oscillations in human esophageal squamous cell carcinoma , 2014, Oncotarget.

[3]  Ju-Seog Lee,et al.  P2X3 purinergic receptor overexpression is associated with poor recurrence-free survival in hepatocellular carcinoma patients , 2015, Oncotarget.

[4]  F. Davis,et al.  Calcium Channels and Pumps in Cancer: Changes and Consequences* , 2012, The Journal of Biological Chemistry.

[5]  M. Schindler,et al.  Synthesis and SERCA activities of structurally simplified cyclopiazonic acid analogues. , 2011, Bioorganic & medicinal chemistry.

[6]  A. Penna,et al.  Pharmacological Characterization and Molecular Determinants of the Activation of Transient Receptor Potential V2 Channel Orthologs by 2-Aminoethoxydiphenyl Borate , 2007, Molecular Pharmacology.

[7]  F. Meyers,et al.  Suramin therapy for patients with symptomatic hormone-refractory prostate cancer: results of a randomized phase III trial comparing suramin plus hydrocortisone to placebo plus hydrocortisone. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  M. Hediger,et al.  Chemical Inhibitors of the Calcium Entry Channel TRPV6 , 2011, Pharmaceutical Research.

[9]  P. Gélébart,et al.  The loss of sarco/endoplasmic reticulum calcium transport ATPase 3 expression is an early event during the multistep process of colon carcinogenesis. , 2005, The American journal of pathology.

[10]  M. Hou,et al.  STIM1 Overexpression Promotes Colorectal Cancer Progression, Cell Motility and COX-2 Expression , 2014, Oncogene.

[11]  Jianjie Ma,et al.  Depletion of Intracellular Ca2+ by Caffeine and Ryanodine Induces Apoptosis of Chinese Hamster Ovary Cells Transfected with Ryanodine Receptor* , 2000, The Journal of Biological Chemistry.

[12]  F. V. van Leeuwen,et al.  Interplay between TRP channels and the cytoskeleton in health and disease. , 2008, European journal of cell biology.

[13]  H. Bitter,et al.  Characterization of a novel CRAC inhibitor that potently blocks human T cell activation and effector functions. , 2013, Molecular immunology.

[14]  K. Mikoshiba,et al.  2APB, 2-aminoethoxydiphenyl borate, a membrane-penetrable modulator of Ins(1,4,5)P3-induced Ca2+ release. , 1997, Journal of biochemistry.

[15]  C. Slomianny,et al.  Calcium-permeable ion channels in control of autophagy and cancer , 2013, Front. Physiol..

[16]  I. Bezprozvanny,et al.  Store-operated calcium entry into SK-N-SH human neuroblastoma cells modeling huntington’s disease , 2012, Biochemistry (Moscow) Supplement Series A: Membrane and Cell Biology.

[17]  T. Vogt,et al.  Inverse regulation of melanoma growth and migration by Orai1/STIM2‐dependent calcium entry , 2014, Pigment cell & melanoma research.

[18]  J. Manola,et al.  Phase II study of carboxyamidotriazole in patients with advanced renal cell carcinoma refractory to immunotherapy , 2005, Cancer.

[19]  Xin-Yun Huang,et al.  Orai1 and STIM1 are critical for breast tumor cell migration and metastasis. , 2009, Cancer cell.

[20]  G. Boivin,et al.  Squamous Cell Tumors in Mice Heterozygous for a Null Allele of Atp2a2, Encoding the Sarco(endo)plasmic Reticulum Ca2+-ATPase Isoform 2 Ca2+Pump* , 2001, The Journal of Biological Chemistry.

[21]  A. Parekh,et al.  Sustained Activation of the Tyrosine Kinase Syk by Antigen in Mast Cells Requires Local Ca2+ Influx through Ca2+ Release-activated Ca2+ Channels* , 2008, Journal of Biological Chemistry.

[22]  Keli Xu,et al.  Calcium oscillations increase the efficiency and specificity of gene expression , 1998, Nature.

[23]  G. Lepage,et al.  Orai1 and STIM1 mediate SOCE and contribute to apoptotic resistance of pancreatic adenocarcinoma. , 2014, Biochimica et biophysica acta.

[24]  Wei Cheng,et al.  Structural mechanism underlying capsaicin binding and activation of TRPV1 ion channel , 2015, Nature chemical biology.

[25]  Jun Gu,et al.  Thapsigargin increases apoptotic cell death in human hepatoma BEL-7404 cells* , 1995, Cell Research.

[26]  Erik Smedler,et al.  Frequency decoding of calcium oscillations. , 2014, Biochimica et biophysica acta.

[27]  S. Orrenius,et al.  The role of calcium in the regulation of apoptosis. , 1996, Journal of leukocyte biology.

[28]  L M Duncan,et al.  Down-regulation of the novel gene melastatin correlates with potential for melanoma metastasis. , 1998, Cancer research.

[29]  P. Song,et al.  The P2Y2 Nucleotide Receptor Mediates the Proliferation and Migration of Human Hepatocellular Carcinoma Cells Induced by ATP* , 2014, The Journal of Biological Chemistry.

[30]  Y. Hu,et al.  High expression of Transient potential receptor C6 correlated with poor prognosis in patients with esophageal squamous cell carcinoma , 2013, Medical Oncology.

[31]  Jung-Hye Choi,et al.  T-type Ca2+ channel blocker, KYS05047 induces G1 phase cell cycle arrest by decreasing intracellular Ca2+ levels in human lung adenocarcinoma A549 cells. , 2012, Bioorganic & medicinal chemistry letters.

[32]  Dimitra Gkika,et al.  TRP channels in prostate cancer: the good, the bad and the ugly? , 2011, Asian journal of andrology.

[33]  G. Barritt,et al.  TRP channels in cancer. , 2007, Biochimica et biophysica acta.

[34]  Qiang Xu,et al.  Novel role of Sarco/endoplasmic reticulum calcium ATPase 2 in development of colorectal cancer and its regulation by F36, a curcumin analog. , 2014, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[35]  G. Santoni,et al.  Expression of transient receptor potential vanilloid‐1 (TRPV1) in urothelial cancers of human bladder: relation to clinicopathological and molecular parameters , 2010, Histopathology.

[36]  H. Kwon,et al.  NNC 55-0396, a T-type Ca2+ channel inhibitor, inhibits angiogenesis via suppression of hypoxia-inducible factor-1α signal transduction , 2014, Journal of Molecular Medicine.

[37]  A. Edelman,et al.  A Regulatory Feedback Loop Between Ca2+/Calmodulin-dependent Protein Kinase Kinase 2 (CaMKK2) and the Androgen Receptor in Prostate Cancer Progression* , 2012, The Journal of Biological Chemistry.

[38]  Y. Lee,et al.  Bepridil enhances in vitro antitumor activity of antiestrogens in human brain tumor cells. , 1996, Cancer letters.

[39]  J. Parys,et al.  The type 2 inositol 1,4,5-trisphosphate receptor, emerging functions for an intriguing Ca²⁺-release channel. , 2015, Biochimica et biophysica acta.

[40]  L. Nie,et al.  Inhibition of proliferation of MCF-7 breast cancer cells by a blocker of Ca(2+)-permeable channel. , 1997, Cell calcium.

[41]  Hana Jin,et al.  P2Y2receptor activation by nucleotides released from highly metastatic breast cancer cells increases tumor growth and invasion via crosstalk with endothelial cells , 2014, Breast Cancer Research.

[42]  K. Mikoshiba,et al.  IP3R2 levels dictate the apoptotic sensitivity of diffuse large B-cell lymphoma cells to an IP3R-derived peptide targeting the BH4 domain of Bcl-2 , 2013, Cell Death and Disease.

[43]  J. Putney,et al.  Comparison of Human TRPC3 Channels in Receptor-activated and Store-operated Modes , 2002, The Journal of Biological Chemistry.

[44]  Heping Cheng,et al.  STIM1- and Orai1-mediated Ca2+ oscillation orchestrates invadopodium formation and melanoma invasion , 2014, The Journal of cell biology.

[45]  Rosemary K. Yee,et al.  TRPM7 and TRPM8 Ion Channels in Pancreatic Adenocarcinoma: Potential Roles as Cancer Biomarkers and Targets , 2012, Scientifica.

[46]  G. Mealing,et al.  In Vivo Detection of Human TRPV6-Rich Tumors with Anti-Cancer Peptides Derived from Soricidin , 2013, PloS one.

[47]  J. Diehl,et al.  Selective Vulnerability of Cancer Cells by Inhibition of Ca(2+) Transfer from Endoplasmic Reticulum to Mitochondria. , 2016, Cell reports.

[48]  Expression of P2X7 receptor increases in vivo tumor growth. , 2012, Cancer research.

[49]  D. O'regan,et al.  Nanomolar potency and selectivity of a Ca2+ release-activated Ca2+ channel inhibitor against store-operated Ca2+ entry and migration of vascular smooth muscle cells , 2011, British journal of pharmacology.

[50]  F. Révillion,et al.  Vitamin‐D3 derivatives and breast‐tumor cell growth: Effect on intracellular calcium and apoptosis , 1995, International journal of cancer.

[51]  D. Chen,et al.  The TRPC channel blocker SKF 96365 inhibits glioblastoma cell growth by enhancing reverse mode of the Na+/Ca2+ exchanger and increasing intracellular Ca2+ , 2014, British journal of pharmacology.

[52]  Richard S Lewis,et al.  Potentiation and inhibition of Ca2+ release‐activated Ca2+ channels by 2‐aminoethyldiphenyl borate (2‐APB) occurs independently of IP3 receptors , 2001, The Journal of physiology.

[53]  Dik‐Lung Ma,et al.  Alisol B, a Novel Inhibitor of the Sarcoplasmic/Endoplasmic Reticulum Ca2+ ATPase Pump, Induces Autophagy, Endoplasmic Reticulum Stress, and Apoptosis , 2010, Molecular Cancer Therapeutics.

[54]  D. Brat,et al.  Caffeine-mediated inhibition of calcium release channel inositol 1,4,5-trisphosphate receptor subtype 3 blocks glioblastoma invasion and extends survival. , 2010, Cancer research.

[55]  Rajender K. Motiani,et al.  Orai3 is an estrogen receptor α‐regulated Ca2+ channel that promotes tumorigenesis , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[56]  S. D. De Pascali,et al.  The platinum (II) complex [Pt(O,O'-acac)(γ-acac)(DMS)] alters the intracellular calcium homeostasis in MCF-7 breast cancer cells. , 2011, Biochemical pharmacology.

[57]  Shuhan Sun,et al.  Blockade of store-operated Ca(2+) entry inhibits hepatocarcinoma cell migration and invasion by regulating focal adhesion turnover. , 2013, Cancer letters.

[58]  K. Kirkwood,et al.  Inhibition of human breast cancer cell proliferation in tissue culture by the neuroleptic agents pimozide and thioridazine. , 1990, Cancer research.

[59]  E. Lamperti,et al.  Dual functions for the endoplasmic reticulum calcium sensors STIM1 and STIM2 in T cell activation and tolerance , 2008, Nature Immunology.

[60]  Nathan T. Ross,et al.  Englerin A Agonizes the TRPC4/C5 Cation Channels to Inhibit Tumor Cell Line Proliferation , 2015, PloS one.

[61]  K. Yamaguchi,et al.  The type III inositol 1,4,5-trisphosphate receptor is associated with aggressiveness of colorectal carcinoma. , 2010, Cell calcium.

[62]  M. Prakriya,et al.  Divergence of Ca 2 + selectivity and equilibrium Ca 2 + blockade in a Ca 2 + release-activated Ca 2 + channel , 2014 .

[63]  J. Roos,et al.  CM3457, a potent and selective oral CRAC channel inhibitor, suppresses T and mast cell function and is efficacious in rat models of arthritis and asthma (72.3) , 2012, Journal of Immunology.

[64]  K. Mikoshiba,et al.  Two novel 2-aminoethyl diphenylborinate (2-APB) analogues differentially activate and inhibit store-operated Ca(2+) entry via STIM proteins. , 2010, Cell calcium.

[65]  M. Hoth,et al.  Potent Inhibition of Ca2+ Release-activated Ca2+ Channels and T-lymphocyte Activation by the Pyrazole Derivative BTP2* , 2004, Journal of Biological Chemistry.

[66]  J. Sullivan,et al.  Generation and Characterization of Fully Human Monoclonal Antibodies Against Human Orai1 for Autoimmune Disease , 2013, The Journal of Pharmacology and Experimental Therapeutics.

[67]  A. M. Sánchez,et al.  Induction of apoptosis in prostate tumor PC-3 cells and inhibition of xenograft prostate tumor growth by the vanilloid capsaicin , 2006, Apoptosis.

[68]  S. Feske,et al.  STIM1 and STIM2-mediated Ca2+ influx regulates antitumour immunity by CD8+ T cells , 2013, EMBO molecular medicine.

[69]  C. Romanin,et al.  The action of selective CRAC channel blockers is affected by the Orai pore geometry , 2013, Cell calcium.

[70]  D. Gordienko,et al.  Identification of ML-9 as a lysosomotropic agent targeting autophagy and cell death , 2014, Cell Death and Disease.

[71]  D. Massi,et al.  Transient receptor potential vanilloid 4 (TRPV4) is downregulated in keratinocytes in human non-melanoma skin cancer. , 2014, The Journal of investigative dermatology.

[72]  G. Wang,et al.  Capsaicin mediates caspases activation and induces apoptosis through P38 and JNK MAPK pathways in human renal carcinoma , 2016, BMC Cancer.

[73]  D. Demarini,et al.  N-((1S)-1-{[4-((2S)-2-{[(2,4-Dichlorophenyl)sulfonyl]amino}-3-hydroxypropanoyl)-1-piperazinyl]carbonyl}-3-methylbutyl)-1-benzothiophene-2-carboxamide (GSK1016790A), a Novel and Potent Transient Receptor Potential Vanilloid 4 Channel Agonist Induces Urinary Bladder Contraction and Hyperactivity: Part , 2008, Journal of Pharmacology and Experimental Therapeutics.

[74]  Mansoor Abdul,et al.  Ryanodine Receptor Expression Correlates with Tumor Grade in Breast Cancer , 2008, Pathology & Oncology Research.

[75]  K. Mikoshiba,et al.  [Possible involvement of inositol 1, 4, 5-trisphosphate receptor type 3 (IP3R3) in the peritoneal dissemination of gastric cancers]. , 2003, Gan to kagaku ryoho. Cancer & chemotherapy.

[76]  M. Prakriya,et al.  Orai1 Mutations Alter Ion Permeation and Ca2+-dependent Fast Inactivation of CRAC Channels: Evidence for Coupling of Permeation and Gating , 2007, The Journal of general physiology.

[77]  Meng Wu,et al.  Identification and optimization of 2‐aminobenzimidazole derivatives as novel inhibitors of TRPC4 and TRPC5 channels , 2015, British journal of pharmacology.

[78]  C. Romanin,et al.  2-Aminoethoxydiphenyl Borate Alters Selectivity of Orai3 Channels by Increasing Their Pore Size* , 2008, Journal of Biological Chemistry.

[79]  K. Jacobson,et al.  Dihydropyridines as inhibitors of capacitative calcium entry in leukemic HL-60 cells. , 2003, Biochemical pharmacology.

[80]  J. Soboloff,et al.  A Functional Link between Store-operated and TRPC Channels Revealed by the 3,5-Bis(trifluoromethyl)pyrazole Derivative, BTP2* , 2005, Journal of Biological Chemistry.

[81]  J. Krebs.  The plethora of PMCA isoforms: Alternative splicing and differential expression. , 2015, Biochimica et biophysica acta.

[82]  Jian-Feng Wang,et al.  Over-expression of Orai1 mediates cell proliferation and associates with poor prognosis in human non-small cell lung carcinoma. , 2015, International journal of clinical and experimental pathology.

[83]  K. Irani,et al.  [Ca2+] i Oscillation Frequency Regulates Agonist-stimulated NF-κB Transcriptional Activity* , 1999, The Journal of Biological Chemistry.

[84]  S. Cha,et al.  Orai1 and STIM1 are critical for cell migration and proliferation of clear cell renal cell carcinoma. , 2014, Biochemical and biophysical research communications.

[85]  P. Cullen.  Calcium Signalling: The Ups and Downs of Protein Kinase C , 2003, Current Biology.

[86]  J. Defalco,et al.  Identification of orally-bioavailable antagonists of the TRPV4 ion-channel. , 2015, Bioorganic & medicinal chemistry letters.

[87]  G. Capellá,et al.  Stromal interaction molecule 2 (STIM2) is frequently overexpressed in colorectal tumors and confers a tumor cell growth suppressor phenotype , 2012, Molecular carcinogenesis.

[88]  R. Rao,et al.  Calcium-ATPases: Gene disorders and dysregulation in cancer. , 2016, Biochimica et biophysica acta.

[89]  M. Prakriya,et al.  Molecular pharmacology of store-operated CRAC channels , 2013, Channels.

[90]  B. Nilius.  TRP channels in disease. , 2007, Biochimica et biophysica acta.

[91]  I. Novak,et al.  The P2X7 receptor regulates cell survival, migration and invasion of pancreatic ductal adenocarcinoma cells , 2015, Molecular Cancer.

[92]  M. Benahmed,et al.  Remodeling of channel-forming ORAI proteins determines an oncogenic switch in prostate cancer. , 2014, Cancer cell.

[93]  B. Bussolati,et al.  TRPV4 mediates tumor-derived endothelial cell migration via arachidonic acid-activated actin remodeling , 2012, Oncogene.

[94]  S. Lakhani,et al.  Calcium Channel TRPV6 as a Potential Therapeutic Target in Estrogen Receptor–Negative Breast Cancer , 2012, Molecular Cancer Therapeutics.

[95]  M. A. Matlib,et al.  Selectivity of inhibition of Na(+)-Ca2+ exchange of heart mitochondria by benzothiazepine CGP-37157. , 1993, Journal of cardiovascular pharmacology.

[96]  Colin W. Taylor,et al.  Interactions of antagonists with subtypes of inositol 1,4,5-trisphosphate (IP3) receptor , 2014, British journal of pharmacology.

[97]  David E. Clapham,et al.  International Union of Basic and Clinical Pharmacology. LXXVI. Current Progress in the Mammalian TRP Ion Channel Family , 2010, Pharmacological Reviews.

[98]  Søren B. Padkjær,et al.  Antibody-Mediated Targeting of the Orai1 Calcium Channel Inhibits T Cell Function , 2013, PloS one.

[99]  Peng Huang,et al.  Effective Killing of Leukemia Cells by the Natural Product OSW-1 through Disruption of Cellular Calcium Homeostasis* , 2012, The Journal of Biological Chemistry.

[100]  M. Ferrer,et al.  Up-regulation of lysosomal TRPML1 channels is essential for lysosomal adaptation to nutrient starvation , 2015, Proceedings of the National Academy of Sciences.

[101]  H. Llewelyn Roderick,et al.  Ca2+ signalling checkpoints in cancer: remodelling Ca2+ for cancer cell proliferation and survival , 2008, Nature Reviews Cancer.

[102]  G. Barritt,et al.  TRPM8 in prostate cancer cells: a potential diagnostic and prognostic marker with a secretory function? , 2006, Endocrine-related cancer.

[103]  D. Im,et al.  N,N-dimethyl-D-erythro-sphingosine increases intracellular Ca2+ concentration via Na+-Ca2+-exchanger in HCT116 human colon cancer cells , 2008, Archives of pharmacal research.

[104]  S. Feske,et al.  Emerging roles of store-operated Ca2+ entry through STIM and ORAI proteins in immunity, hemostasis and cancer , 2013, Channels.

[105]  E. Kohn,et al.  CAI inhibits the growth of small cell lung cancer cells. , 2003, Lung cancer.

[106]  T. Ishibashi,et al.  G1 cell cycle arrest by amlodipine, a dihydropyridine Ca2+ channel blocker, in human epidermoid carcinoma A431 cells. , 2007, Biochemical pharmacology.

[107]  U. Pati,et al.  p53 Increases Intra-Cellular Calcium Release by Transcriptional Regulation of Calcium Channel TRPC6 in GaQ3-Treated Cancer Cells , 2013, PloS one.

[108]  K. Sankaranarayanan,et al.  Glu106 targeted inhibitors of ORAI1 as potential Ca2+ release-activated Ca2+ (CRAC) channel blockers – molecular modeling and docking studies , 2016, Journal of receptor and signal transduction research.

[109]  Yassine El Hiani,et al.  Activation of the calcium-sensing receptor by high calcium induced breast cancer cell proliferation and TRPC1 cation channel over-expression potentially through EGFR pathways. , 2009, Archives of biochemistry and biophysics.

[110]  P. Kenny,et al.  ORAI1-Mediated Calcium Influx in Lactation and in Breast Cancer , 2011, Molecular Cancer Therapeutics.

[111]  Hsien-Chang Chang,et al.  Calcium store sensor stromal-interaction molecule 1-dependent signaling plays an important role in cervical cancer growth, migration, and angiogenesis , 2011, Proceedings of the National Academy of Sciences.

[112]  Sarah J. Roberts-Thomson,et al.  Store-Independent Activation of Orai1 by SPCA2 in Mammary Tumors , 2010, Cell.

[113]  T. Macdonald,et al.  Inhibition of human prostate cancer proliferation in vitro and in a mouse model by a compound synthesized to block Ca2+ entry. , 2000, Cancer research.

[114]  A. M. Sánchez,et al.  Expression of the transient receptor potential vanilloid 1 (TRPV1) in LNCaP and PC-3 prostate cancer cells and in human prostate tissue. , 2005, European journal of pharmacology.

[115]  Shenyuan L. Zhang,et al.  Molecular identification of the CRAC channel by altered ion selectivity in a mutant of Orai , 2006, Nature.

[116]  P. Kenny,et al.  Mitochondrial calcium uniporter silencing potentiates caspase-independent cell death in MDA-MB-231 breast cancer cells. , 2013, Biochemical and biophysical research communications.

[117]  K. Honda,et al.  YM-58483, a selective CRAC channel inhibitor, prevents antigen-induced airway eosinophilia and late phase asthmatic responses via Th2 cytokine inhibition in animal models. , 2007, European journal of pharmacology.

[118]  György Hajnóczky,et al.  Imaging interorganelle contacts and local calcium dynamics at the ER-mitochondrial interface. , 2010, Molecular cell.

[119]  M. Estrada,et al.  Xestospongin B, a competitive inhibitor of IP3‐mediated Ca2+ signalling in cultured rat myotubes, isolated myonuclei, and neuroblastoma (NG108‐15) cells , 2005, FEBS letters.

[120]  D. Ingber,et al.  Activation of mechanosensitive ion channel TRPV4 normalizes tumor vasculature and improves cancer therapy , 2015, Oncogene.

[121]  K. Uzawa,et al.  Plasma membrane Ca2+ ATPase isoform 1 down-regulated in human oral cancer. , 2006, Oncology reports.

[122]  L. Gray,et al.  T-type calcium channels blockers as new tools in cancer therapies , 2014, Pflügers Archiv - European Journal of Physiology.

[123]  H. Sevestre,et al.  TRP channels: diagnostic markers and therapeutic targets for breast cancer? , 2013, Trends in molecular medicine.

[124]  J. Kinet,et al.  A Pyrazole Derivative Potently Inhibits Lymphocyte Ca2+ Influx and Cytokine Production by Facilitating Transient Receptor Potential Melastatin 4 Channel Activity , 2006, Molecular Pharmacology.

[125]  S. Christensen,et al.  Engineering a prostate-specific membrane antigen-activated tumor endothelial cell prodrug for cancer therapy (Science Translational Medicine) , 2012 .

[126]  S. Atkin,et al.  TRPC channels and their splice variants are essential for promoting human ovarian cancer cell proliferation and tumorigenesis. , 2012, Current cancer drug targets.

[127]  Qiang Xu,et al.  Small molecule RL71 targets SERCA2 at a novel site in the treatment of human colorectal cancer , 2015, Oncotarget.

[128]  P. Dasgupta,et al.  Capsaicin induces apoptosis in human small cell lung cancer via the TRPV6 receptor and the calpain pathway , 2014, Apoptosis.

[129]  V. Mootha,et al.  MICU1 controls both the threshold and cooperative activation of the mitochondrial Ca²⁺ uniporter. , 2013, Cell metabolism.

[130]  A. Edelman,et al.  Effect of ouabain on CFTR gene expression in human Calu-3 cells. , 2003, American journal of physiology. Cell physiology.

[131]  B. Costa,et al.  Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation , 2004, British journal of pharmacology.

[132]  E. Kohn,et al.  Carboxyamido-triazole (CAI), a signal transduction inhibitor induces growth inhibition and apoptosis in bladder cancer cells by modulation of Bcl-2. , 2004, Anticancer research.

[133]  R. Schiffmann,et al.  A small molecule restores function to TRPML1 mutant isoforms responsible for mucolipidosis type IV , 2014, Nature Communications.

[134]  A. A. Mongin,et al.  STIM1 and Orai1 mediate CRAC channel activity and are essential for human glioblastoma invasion , 2013, Pflügers Archiv - European Journal of Physiology.

[135]  W. Lee,et al.  Plasma membrane calcium-ATPase 2 and 4 in human breast cancer cell lines. , 2005, Biochemical and biophysical research communications.

[136]  A. A. Romanovsky,et al.  Pharmacological Blockade of the Cold Receptor TRPM8 Attenuates Autonomic and Behavioral Cold Defenses and Decreases Deep Body Temperature , 2012, The Journal of Neuroscience.

[137]  M. Shapero,et al.  Trp-p8, a novel prostate-specific gene, is up-regulated in prostate cancer and other malignancies and shares high homology with transient receptor potential calcium channel proteins. , 2001, Cancer research.

[138]  J. Bruce,et al.  Pharmacological evaluation of the role of cytochrome P450 in intracellular calcium signalling in rat pancreatic acinar cells , 2000, British journal of pharmacology.

[139]  R. Tsien,et al.  Voltage-gated calcium channels, calcium signaling, and channelopathies , 2007 .

[140]  P. Poronnik,et al.  Plasma membrane Ca2+-ATPase expression during colon cancer cell line differentiation. , 2007, Biochemical and biophysical research communications.

[141]  F. Michelangeli,et al.  Saikosaponin-d, a novel SERCA inhibitor, induces autophagic cell death in apoptosis-defective cells , 2013, Cell Death and Disease.

[142]  C. Romanin,et al.  TRPV6 calcium channel translocates to the plasma membrane via Orai1-mediated mechanism and controls cancer cell survival , 2014, Proceedings of the National Academy of Sciences.

[143]  S. Christensen,et al.  Engineering a Prostate-Specific Membrane Antigen–Activated Tumor Endothelial Cell Prodrug for Cancer Therapy , 2012, Science Translational Medicine.

[144]  Pan Zui,et al.  Special Topic: Calcium Signaling Open Sesame: Treasure in Store-operated Calcium Entry Pathway for Cancer Therapy , 2022 .

[145]  D. Traver,et al.  Loss of IP3R-dependent Ca2+ signalling in thymocytes leads to aberrant development and acute lymphoblastic leukemia , 2014, Nature Communications.

[146]  J. Levijoki,et al.  ORM‐10103, a novel specific inhibitor of the Na+/Ca2+ exchanger, decreases early and delayed afterdepolarizations in the canine heart , 2013, British journal of pharmacology.

[147]  M. Prakriya,et al.  Competitive Modulation of Ca2+ Release-activated Ca2+ Channel Gating by STIM1 and 2-Aminoethyldiphenyl Borate* , 2010, The Journal of Biological Chemistry.

[148]  N. Yee.  Roles of TRPM8 Ion Channels in Cancer: Proliferation, Survival, and Invasion , 2015, Cancers.

[149]  Kamlesh Asotra,et al.  Calcium wave signaling in cancer cells. , 2010, Life sciences.

[150]  N. Kirma,et al.  Vanilloids induce oral cancer apoptosis independent of TRPV1. , 2014, Oral oncology.

[151]  Elena De Marchi,et al.  Emerging roles of P2X receptors in cancer. , 2015, Current medicinal chemistry.

[152]  H. Sevestre,et al.  Orai3 Constitutes a Native Store-Operated Calcium Entry That Regulates Non Small Cell Lung Adenocarcinoma Cell Proliferation , 2013, PloS one.

[153]  Herbert Waldmann,et al.  (-)-Englerin A is a potent and selective activator of TRPC4 and TRPC5 calcium channels. , 2015, Angewandte Chemie.

[154]  C. Porta,et al.  Orai1 and transient receptor potential channels as novel molecular targets to impair tumor neovascularization in renal cell carcinoma and other malignancies. , 2014, Anti-cancer agents in medicinal chemistry.

[155]  Rajender K. Motiani,et al.  A Novel Native Store-operated Calcium Channel Encoded by Orai3 , 2010, The Journal of Biological Chemistry.

[156]  J. Parys,et al.  Modification of Store-operated Channel Coupling and Inositol Trisphosphate Receptor Function by 2-Aminoethoxydiphenyl Borate in DT40 Lymphocytes* , 2002, The Journal of Biological Chemistry.

[157]  A. Sandoval,et al.  Ghrelin inhibits proliferation and increases T-type Ca2+ channel expression in PC-3 human prostate carcinoma cells. , 2010, Biochemical and biophysical research communications.

[158]  M. Brevet,et al.  High Expression of Transient Receptor Potential Channels in Human Breast Cancer Epithelial Cells and Tissues: Correlation with Pathological Parameters , 2011, Cellular Physiology and Biochemistry.

[159]  K. Mikoshiba.  IP3 receptors and their role in cell function , 2007 .

[160]  M. Rowe,et al.  Modulation of B-cell endoplasmic reticulum calcium homeostasis by Epstein-Barr virus Latent Membrane Protein-1 , 2009, Molecular Cancer.

[161]  H. Sevestre,et al.  Evidence that TRPM7 is required for breast cancer cell proliferation. , 2009, American journal of physiology. Cell physiology.

[162]  J. Yamazaki,et al.  T-type voltage-activated calcium channel Cav3.1, but not Cav3.2, is involved in the inhibition of proliferation and apoptosis in MCF-7 human breast cancer cells. , 2012, International journal of oncology.

[163]  M. Lai,et al.  Meta-Analysis of Public Microarray Datasets Reveals Voltage-Gated Calcium Gene Signatures in Clinical Cancer Patients , 2015, PloS one.

[164]  V. Pinelis,et al.  KB‐R7943, an inhibitor of the reverse Na+/Ca2+ exchanger, blocks N‐methyl‐D‐aspartate receptor and inhibits mitochondrial complex I , 2011, British journal of pharmacology.

[165]  Yi Liu,et al.  TRPM8 in health and disease: cold sensing and beyond. , 2011, Advances in experimental medicine and biology.

[166]  R. Ramer,et al.  Cannabidiol inhibits lung cancer cell invasion and metastasis via intercellular adhesion molecule‐1 , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[167]  M. Prakriya,et al.  Divergence of Ca2+ selectivity and equilibrium Ca2+ blockade in a Ca2+ release-activated Ca2+ channel , 2014, The Journal of general physiology.

[168]  Aaron M. Beedle,et al.  Expression of T‐type calcium channel splice variants in human glioma , 2004, Glia.

[169]  A. Parekh,et al.  Decoding cytosolic Ca2+ oscillations. , 2011, Trends in biochemical sciences.

[170]  C. Romanin,et al.  Orai1 contributes to the establishment of an apoptosis-resistant phenotype in prostate cancer cells , 2010, Cell Death and Disease.

[171]  Č. Vlček,et al.  Melanoma cells influence the differentiation pattern of human epidermal keratinocytes , 2015, Molecular Cancer.

[172]  P. Brookes,et al.  Calcium, ATP, and ROS: a mitochondrial love-hate triangle. , 2004, American journal of physiology. Cell physiology.

[173]  C. Romanin,et al.  Novel pyrazole compounds for pharmacological discrimination between receptor-operated and store-operated Ca2+ entry pathways , 2012, British journal of pharmacology.

[174]  E. Aydar,et al.  Abnormal expression, localization and interaction of canonical transient receptor potential ion channels in human breast cancer cell lines and tissues: a potential target for breast cancer diagnosis and therapy , 2009, Cancer Cell International.

[175]  R. Gaudet,et al.  What do we know about the transient receptor potential vanilloid 2 (TRPV2) ion channel? , 2013, The FEBS journal.

[176]  T. Rink,et al.  SK&F 96365, a novel inhibitor of receptor-mediated calcium entry. , 1990, The Biochemical journal.

[177]  M. Berridge,et al.  The versatility and universality of calcium signalling , 2000, Nature Reviews Molecular Cell Biology.

[178]  J. McCray,et al.  Repurposing and Rescuing of Mibefradil, an Antihypertensive, for Cancer: A Case Study. , 2015, Assay and drug development technologies.

[179]  H. Sevestre,et al.  Estrogen regulation of TRPM8 expression in breast cancer cells , 2010, BMC Cancer.

[180]  S. Miyamoto,et al.  Xestospongin C, a selective and membrane‐permeable inhibitor of IP3 receptor, attenuates the positive inotropic effect of α‐adrenergic stimulation in guinea‐pig papillary muscle , 2000, British journal of pharmacology.

[181]  L. Núñez,et al.  A Reciprocal Shift in Transient Receptor Potential Channel 1 (TRPC1) and Stromal Interaction Molecule 2 (STIM2) Contributes to Ca2+ Remodeling and Cancer Hallmarks in Colorectal Carcinoma Cells* , 2014, The Journal of Biological Chemistry.

[182]  I. Vetter,et al.  Golgi Calcium Pump Secretory Pathway Calcium ATPase 1 (SPCA1) Is a Key Regulator of Insulin-like Growth Factor Receptor (IGF1R) Processing in the Basal-like Breast Cancer Cell Line MDA-MB-231* , 2010, The Journal of Biological Chemistry.

[183]  H. Sevestre,et al.  Down‐regulation of Orai3 arrests cell‐cycle progression and induces apoptosis in breast cancer cells but not in normal breast epithelial cells , 2011, Journal of cellular physiology.

[184]  N. Prevarskaya,et al.  The role of the TRPV6 channel in cancer , 2012, The Journal of physiology.

[185]  Melissa R. Miller,et al.  Identification of ML204, a Novel Potent Antagonist That Selectively Modulates Native TRPC4/C5 Ion Channels* , 2011, The Journal of Biological Chemistry.

[186]  R. Kiss,et al.  Wittig derivatization of sesquiterpenoid polygodial leads to cytostatic agents with activity against drug resistant cancer cells and capable of pyrrolylation of primary amines. , 2015, European journal of medicinal chemistry.

[187]  Kechun Zhou,et al.  Transient receptor potential channel C3 contributes to the progression of human ovarian cancer , 2009, Oncogene.

[188]  Kechun Zhou,et al.  Essential role of TRPC6 channels in G2/M phase transition and development of human glioma. , 2010, Journal of the National Cancer Institute.

[189]  M. Roudbaraki,et al.  Evidence of functional ryanodine receptor involved in apoptosis of prostate cancer (LNCaP) cells , 2000, The Prostate.

[190]  T. Bisogno,et al.  Effects of cannabinoids and cannabinoid‐enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes , 2011, British journal of pharmacology.

[191]  M. Berridge.  The AM and FM of calcium signalling , 1997, Nature.

[192]  D. Kass,et al.  Combined TRPC3 and TRPC6 blockade by selective small-molecule or genetic deletion inhibits pathological cardiac hypertrophy , 2014, Proceedings of the National Academy of Sciences.

[193]  Mun Kyung Hwang,et al.  20-O-β-d-glucopyranosyl-20(S)-protopanaxadiol, a metabolite of ginseng, inhibits colon cancer growth by targeting TRPC channel-mediated calcium influx. , 2013, The Journal of nutritional biochemistry.

[194]  Simion I. Chiosea,et al.  Genetic landscape of metastatic and recurrent head and neck squamous cell carcinoma. , 2016, The Journal of clinical investigation.

[195]  M. Birnbaum,et al.  MICU1 Is an Essential Gatekeeper for MCU-Mediated Mitochondrial Ca2+ Uptake that Regulates Cell Survival , 2012, Cell.

[196]  Yizheng Wang,et al.  Targeting TRPC6 channels in oesophageal carcinoma growth , 2010, Expert opinion on therapeutic targets.

[197]  M. Prakriya,et al.  Gated regulation of CRAC channel ion selectivity by STIM1 , 2011, Nature.

[198]  F. Gackière,et al.  CaV3.2 T-type Calcium Channels Are Involved in Calcium-dependent Secretion of Neuroendocrine Prostate Cancer Cells* , 2008, Journal of Biological Chemistry.

[199]  N. Bottini,et al.  Ion channel TRPV1-dependent activation of PTP1B suppresses EGFR-associated intestinal tumorigenesis. , 2014, The Journal of clinical investigation.

[200]  W. Catterall.  Structure and regulation of voltage-gated Ca2+ channels. , 2000, Annual review of cell and developmental biology.

[201]  J. Putney,et al.  Ca2+-store-dependent and -independent reversal of Stim1 localization and function , 2008, Journal of Cell Science.

[202]  G. Wang,et al.  Induction of the , 1996 .

[203]  M. Jakupec,et al.  Inhibitory Effects of the Ruthenium Complex KP1019 in Models of Mammary Cancer Cell Migration and Invasion , 2009, Metal-based drugs.

[204]  D. Dávila,et al.  The use of cannabinoids as anticancer agents , 2016, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[205]  V. Costa,et al.  The Multifaceted Role of Annexin A1 in Viral Infections , 2023, Cells.

[206]  S. Amin,et al.  Targeting ion channels for cancer therapy by repurposing the approved drugs. , 2015, Biochimica et biophysica acta.

[207]  S. Nordgren,et al.  P2Y2- and P2Y4 purinergic receptors are over-expressed in human colon cancer. , 2007, Autonomic & autacoid pharmacology.

[208]  David P. Wilson,et al.  Glu¹⁰⁶ in the Orai1 pore contributes to fast Ca²⁺-dependent inactivation and pH dependence of Ca²⁺ release-activated Ca²⁺ (CRAC) current. , 2012, The Biochemical journal.

[209]  M. Negrini,et al.  Downregulation of the Mitochondrial Calcium Uniporter by Cancer-Related miR-25 , 2013, Current Biology.

[210]  R. Dolmetsch,et al.  Identification of Orai1 channel inhibitors by using minimal functional domains to screen small molecule microarrays. , 2014, Chemistry & biology.

[211]  Carlotta Giorgi,et al.  Ca(2+) transfer from the ER to mitochondria: when, how and why. , 2009, Biochimica et biophysica acta.